Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Karyopharm Therapeutics
Karyopharm Therapeutics
(KPTI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Xpovio
Selinexor
2019-07-03
2032-2035
Multiple myeloma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Selinexor
neoplasm metastasis
,
biphenotypic leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
hematologic neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
skin neoplasms
,
cutaneous malignant melanoma
,
rectal neoplasms
,
aggression
,
ewing sarcoma
,
stomach neoplasms
,
esophageal neoplasms
,
gliosarcoma
,
chromosome aberrations
,
b-cell chronic lymphocytic leukemia
,
prolymphocytic leukemia
,
lymphoid leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
endometrial stromal sarcoma
,
hodgkin disease
,
brain neoplasms
,
nervous system neoplasms
,
immunoglobulin light-chain amyloidosis
,
amyloidosis
,
hepatocellular carcinoma
,
liver neoplasms
,
phenylketonurias
,
hematopoietic stem cell transplantation
,
sarcoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
myelodysplastic syndromes
,
carcinoma
,
non-hodgkin lymphoma
,
ovarian neoplasms
,
glioblastoma
,
neurofibrosarcoma
,
extranodal nk-t-cell lymphoma
,
central nervous system neoplasms
,
preleukemia
,
syndrome
,
breast neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
lung neoplasms
,
melanoma
,
colorectal neoplasms
,
nerve sheath neoplasms
,
glioma
,
glandular and epithelial neoplasms
,
small cell lung carcinoma
,
thrombocytopenia
,
squamous cell neoplasms
,
alveolar soft part sarcoma
,
adenocarcinoma
,
pancreatic ductal carcinoma
,
prostatic neoplasms
,
leiomyosarcoma
,
coronavirus infections
,
thymoma
,
thymus neoplasms
,
rhabdoid tumor
,
myoepithelioma
,
drug-related side effects and adverse reactions
,
gastrointestinal stromal tumors
,
maximum tolerated dose
,
recreational drug use
,
pancreatic neoplasms
,
acinar cell carcinoma
,
squamous cell carcinoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
waldenstrom macroglobulinemia
,
urologic neoplasms
,
transitional cell carcinoma
,
infections
,
communicable diseases
,
diabetic foot
,
ulcer
,
foot ulcer
,
t-cell lymphoma cutaneous
,
neuroendocrine carcinoma
,
uterine cervical neoplasms
,
smoldering multiple myeloma
,
residual neoplasm
,
ovarian epithelial carcinoma
,
wilms tumor
,
osteosarcoma
,
chondrosarcoma
,
clear cell sarcoma
,
fibrosarcoma
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
synovial sarcoma
,
myxoid liposarcoma
,
benign fibrous histiocytoma
,
glomus tumor
,
disorders of sex development
,
dermatofibrosarcoma
,
adipose tissue neoplasms
,
granular cell tumor
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
,
anemia
,
refractory anemia with excess of blasts
,
multiple myeloma
,
myeloid leukemia acute
,
plasma cell neoplasms
,
recurrence
,
neoplasms
,
leukemia
,
myeloid leukemia
,
primary myelofibrosis
,
endometrial neoplasms
,
liposarcoma
,
covid-19
,
myeloproliferative disorders
,
virus diseases
,
uterine neoplasms
,
neoplasms by site
,
uterine diseases
,
genital diseases
,
epstein-barr virus infections
,
hemophagocytic lymphohistiocytosis
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
mantle-cell lymphoma
,
salivary gland neoplasms
,
mothers
,
myeloid sarcoma
Mafodotin
carcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
multiple myeloma
,
plasma cell neoplasms
,
glioma
,
follicular lymphoma
,
glioblastoma
,
brain neoplasms
,
gliosarcoma
ELTANEXOR
myelodysplastic syndromes
,
myeloid leukemia acute
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
colorectal neoplasms
,
multiple myeloma
,
plasma cell neoplasms
,
preleukemia
Mezigdomide
healthy volunteers/patients
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
plasma cell neoplasms
,
neoplasms
,
myeloid leukemia acute
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
biphenotypic leukemia acute
,
multiple myeloma
,
recurrence
PADNARSERTIB
neoplasms
,
melanoma
,
myeloid leukemia acute
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use